Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 20, Number 4—April 2014

Volume 20, Number 4—April 2014   PDF Version [PDF - 10.30 MB - 223 pages]

Synopses

  • Distribution of Pandemic Influenza Vaccine and Reporting of Doses Administered, New York, New York, USA PDF Version [PDF - 937 KB - 7 pages]
    R. Marcello et al.
    View Summary

    Mandating reporting of all doses administered during an influenza pandemic was feasible.

        View Abstract

    In 2009, the New York City Department of Health and Mental Hygiene delivered influenza A(H1N1)pdm09 (pH1N1) vaccine to health care providers, who were required to report all administered doses to the Citywide Immunization Registry. Using data from this registry and a provider survey, we estimated the number of all pH1N1 vaccine doses administered. Of 2.8 million doses distributed during October 1, 2009–March 4, 2010, a total of 988,298 doses were administered and reported; another 172,289 doses were administered but not reported, for a total of 1,160,587 doses administered during this period. Reported doses represented an estimated 80%–85% of actual doses administered. Reporting by a wide range of provider types was feasible during a pandemic. Pediatric-care providers had the highest reporting rate (93%). Other private-care providers who routinely did not report vaccinations indicated that they had few, if any, problems, thereby suggesting that mandatory reporting of all vaccines would be feasible.

        Cite This Article
    EID Marcello R, Papadouka V, Misener M, Wake E, Mandell R, Zucker JR, et al. Distribution of Pandemic Influenza Vaccine and Reporting of Doses Administered, New York, New York, USA. Emerg Infect Dis. 2014;20(4):525-531. https://dx.doi.org/10.3201/eid2004.131114
    AMA Marcello R, Papadouka V, Misener M, et al. Distribution of Pandemic Influenza Vaccine and Reporting of Doses Administered, New York, New York, USA. Emerging Infectious Diseases. 2014;20(4):525-531. doi:10.3201/eid2004.131114.
    APA Marcello, R., Papadouka, V., Misener, M., Wake, E., Mandell, R., & Zucker, J. R. (2014). Distribution of Pandemic Influenza Vaccine and Reporting of Doses Administered, New York, New York, USA. Emerging Infectious Diseases, 20(4), 525-531. https://dx.doi.org/10.3201/eid2004.131114.

Research

  • Antibodies against MERS Coronavirus in Dromedary Camels, United Arab Emirates, 2003 and 2013 PDF Version [PDF - 493 KB - 8 pages]
    B. Meyer et al.
    View Summary

    Camels were infected with this virus >10 years before the first human cases.

        View Abstract

    Middle East respiratory syndrome coronavirus (MERS-CoV) has caused an ongoing outbreak of severe acute respiratory tract infection in humans in the Arabian Peninsula since 2012. Dromedary camels have been implicated as possible viral reservoirs. We used serologic assays to analyze 651 dromedary camel serum samples from the United Arab Emirates; 151 of 651 samples were obtained in 2003, well before onset of the current epidemic, and 500 serum samples were obtained in 2013. Recombinant spike protein–specific immunofluorescence and virus neutralization tests enabled clear discrimination between MERS-CoV and bovine CoV infections. Most (632/651, 97.1%) camels had antibodies against MERS-CoV. This result included all 151 serum samples obtained in 2003. Most (389/651, 59.8%) serum samples had MERS-CoV–neutralizing antibody titers >1,280. Dromedary camels from the United Arab Emirates were infected at high rates with MERS-CoV or a closely related, probably conspecific, virus long before the first human MERS cases.

        Cite This Article
    EID Meyer B, Müller MA, Corman VM, Reusken C, Ritz D, Godeke G, et al. Antibodies against MERS Coronavirus in Dromedary Camels, United Arab Emirates, 2003 and 2013. Emerg Infect Dis. 2014;20(4):552-559. https://dx.doi.org/10.3201/eid2004.131746
    AMA Meyer B, Müller MA, Corman VM, et al. Antibodies against MERS Coronavirus in Dromedary Camels, United Arab Emirates, 2003 and 2013. Emerging Infectious Diseases. 2014;20(4):552-559. doi:10.3201/eid2004.131746.
    APA Meyer, B., Müller, M. A., Corman, V. M., Reusken, C., Ritz, D., Godeke, G....Drosten, C. (2014). Antibodies against MERS Coronavirus in Dromedary Camels, United Arab Emirates, 2003 and 2013. Emerging Infectious Diseases, 20(4), 552-559. https://dx.doi.org/10.3201/eid2004.131746.
  • Ciprofloxacin Resistance and Gonorrhea Incidence Rates in 17 Cities, United States, 1991–2006 PDF Version [PDF - 480 KB - 8 pages]
    H. W. Chesson et al.
    View Summary

    Antimicrobial drug resistance can lead to increases in gonorrhea incidence rates.

        View Abstract

    Antimicrobial drug resistance can hinder gonorrhea prevention and control efforts. In this study, we analyzed historical ciprofloxacin resistance data and gonorrhea incidence data to examine the possible effect of antimicrobial drug resistance on gonorrhea incidence at the population level. We analyzed data from the Gonococcal Isolate Surveillance Project and city-level gonorrhea incidence rates from surveillance data for 17 cities during 1991–2006. We found a strong positive association between ciprofloxacin resistance and gonorrhea incidence rates at the city level during this period. Their association was consistent with predictions of mathematical models in which resistance to treatment can increase gonorrhea incidence rates through factors such as increased duration of infection. These findings highlight the possibility of future increases in gonorrhea incidence caused by emerging cephalosporin resistance.

        Cite This Article
    EID Chesson HW, Kirkcaldy RD, Gift TL, Owusu-Edusei K, Weinstock HS. Ciprofloxacin Resistance and Gonorrhea Incidence Rates in 17 Cities, United States, 1991–2006. Emerg Infect Dis. 2014;20(4):612-619. https://dx.doi.org/10.3201/eid2004.131288
    AMA Chesson HW, Kirkcaldy RD, Gift TL, et al. Ciprofloxacin Resistance and Gonorrhea Incidence Rates in 17 Cities, United States, 1991–2006. Emerging Infectious Diseases. 2014;20(4):612-619. doi:10.3201/eid2004.131288.
    APA Chesson, H. W., Kirkcaldy, R. D., Gift, T. L., Owusu-Edusei, K., & Weinstock, H. S. (2014). Ciprofloxacin Resistance and Gonorrhea Incidence Rates in 17 Cities, United States, 1991–2006. Emerging Infectious Diseases, 20(4), 612-619. https://dx.doi.org/10.3201/eid2004.131288.
  • Active Surveillance for Avian Influenza Virus, Egypt, 2010–2012 PDF Version [PDF - 799 KB - 10 pages]
    G. Kayali et al.
    View Summary

    Continued circulation of influenza virus A subtypes H5N1 and H9N2 highlights the need for a revised intervention plan.

        View Abstract

    Continuous circulation of influenza A(H5N1) virus among poultry in Egypt has created an epicenter in which the viruses evolve into newer subclades and continue to cause disease in humans. To detect influenza viruses in Egypt, since 2009 we have actively surveyed various regions and poultry production sectors. From August 2010 through January 2013, >11,000 swab samples were collected; 10% were positive by matrix gene reverse transcription PCR. During this period, subtype H9N2 viruses emerged, cocirculated with subtype H5N1 viruses, and frequently co-infected the same avian host. Genetic and antigenic analyses of viruses revealed that influenza A(H5N1) clade 2.2.1 viruses are dominant and that all subtype H9N2 viruses are G1-like. Cocirculation of different subtypes poses concern for potential reassortment. Avian influenza continues to threaten public and animal health in Egypt, and continuous surveillance for avian influenza virus is needed.

        Cite This Article
    EID Kayali G, Kandeil A, El-Shesheny R, Kayed AS, Gomaa MM, Maatouq AM, et al. Active Surveillance for Avian Influenza Virus, Egypt, 2010–2012. Emerg Infect Dis. 2014;20(4):542-551. https://dx.doi.org/10.3201/eid2004.131295
    AMA Kayali G, Kandeil A, El-Shesheny R, et al. Active Surveillance for Avian Influenza Virus, Egypt, 2010–2012. Emerging Infectious Diseases. 2014;20(4):542-551. doi:10.3201/eid2004.131295.
    APA Kayali, G., Kandeil, A., El-Shesheny, R., Kayed, A. S., Gomaa, M. M., Maatouq, A. M....Ali, M. A. (2014). Active Surveillance for Avian Influenza Virus, Egypt, 2010–2012. Emerging Infectious Diseases, 20(4), 542-551. https://dx.doi.org/10.3201/eid2004.131295.
  • Contact Investigation for Imported Case of Middle East Respiratory Syndrome, Germany PDF Version [PDF - 359 KB - 6 pages]
    A. Reuss et al.
    View Summary

    No evidence was found for nosocomial transmission of this coronavirus.

        View Abstract

    On March 19, 2013, a patient from United Arab Emirates who had severe respiratory infection was transferred to a hospital in Germany, 11 days after symptom onset. Infection with Middle East respiratory syndrome coronavirus (MERS-CoV) was suspected on March 21 and confirmed on March 23; the patient, who had contact with an ill camel shortly before symptom onset, died on March 26. A contact investigation was initiated to identify possible person-to-person transmission and assess infection control measures. Of 83 identified contacts, 81 were available for follow-up. Ten contacts experienced mild symptoms, but test results for respiratory and serum samples were negative for MERS-CoV. Serologic testing was done for 53 (75%) of 71 nonsymptomatic contacts; all results were negative. Among contacts, the use of FFP2/FFP3 face masks during aerosol exposure was more frequent after MERS-CoV infection was suspected than before. Infection control measures may have prevented nosocomial transmission of the virus.

        Cite This Article
    EID Reuss A, Litterst A, Drosten C, Seilmaier M, Böhmer M, Graf P, et al. Contact Investigation for Imported Case of Middle East Respiratory Syndrome, Germany. Emerg Infect Dis. 2014;20(4):620-625. https://dx.doi.org/10.3201/eid2004.131375
    AMA Reuss A, Litterst A, Drosten C, et al. Contact Investigation for Imported Case of Middle East Respiratory Syndrome, Germany. Emerging Infectious Diseases. 2014;20(4):620-625. doi:10.3201/eid2004.131375.
    APA Reuss, A., Litterst, A., Drosten, C., Seilmaier, M., Böhmer, M., Graf, P....Buchholz, U. (2014). Contact Investigation for Imported Case of Middle East Respiratory Syndrome, Germany. Emerging Infectious Diseases, 20(4), 620-625. https://dx.doi.org/10.3201/eid2004.131375.
  • Efficiency of Points of Dispensing for Influenza A(H1N1)pdm09 Vaccination, Los Angeles County, California, USA, 2009 PDF Version [PDF - 462 KB - 6 pages]
    S. Saha et al.
    View Summary

    Placing vaccine clinics in high population density areas could be an effective strategy to reach large numbers of people.

        View Abstract

    During October 23–December 8, 2009, the Los Angeles County Department of Public Health used points of dispensing (PODs) to improve access to and increase the number of vaccinations against influenza A(H1N1)pdm09. We assessed the efficiency of these units and access to vaccines among ethnic groups. An average of 251 persons per hour (SE 65) were vaccinated at the PODs; a 10% increase in use of live-attenuated monovalent vaccines reduced that rate by 23 persons per hour (SE 7). Vaccination rates were highest for Asians (257/10,000 persons), followed by Hispanics (114/10,000), whites (75/100,000), and African Americans (37/10,000). Average distance traveled to a POD was highest for whites (6.6 miles; SD 6.5) and lowest for Hispanics (4.7 miles; SD ±5.3). Placing PODs in areas of high population density could be an effective strategy to reach large numbers of persons for mass vaccination, but additional PODs may be needed to improve coverage for specific populations.

        Cite This Article
    EID Saha S, Dean B, Teutsch S, Borse RH, Meltzer MI, Bagwell D, et al. Efficiency of Points of Dispensing for Influenza A(H1N1)pdm09 Vaccination, Los Angeles County, California, USA, 2009. Emerg Infect Dis. 2014;20(4):590-595. https://dx.doi.org/10.3201/eid2004.130725
    AMA Saha S, Dean B, Teutsch S, et al. Efficiency of Points of Dispensing for Influenza A(H1N1)pdm09 Vaccination, Los Angeles County, California, USA, 2009. Emerging Infectious Diseases. 2014;20(4):590-595. doi:10.3201/eid2004.130725.
    APA Saha, S., Dean, B., Teutsch, S., Borse, R. H., Meltzer, M. I., Bagwell, D....Fielding, J. (2014). Efficiency of Points of Dispensing for Influenza A(H1N1)pdm09 Vaccination, Los Angeles County, California, USA, 2009. Emerging Infectious Diseases, 20(4), 590-595. https://dx.doi.org/10.3201/eid2004.130725.
  • Epidemic of Mumps among Vaccinated Persons, the Netherlands, 2009–2012 PDF Version [PDF - 694 KB - 6 pages]
    J. Sane et al.
    View Summary

    Mainly vaccinated students were affected, indicating inadequate vaccine effectiveness, but vaccination reduced risk for complications.

        View Abstract

    To analyze the epidemiology of a nationwide mumps epidemic in the Netherlands, we reviewed 1,557 notified mumps cases in persons who had disease onset during September 1, 2009–August 31, 2012. Seasonality peaked in spring and autumn. Most case-patients were males (59%), 18–25 years of age (67.9%), and vaccinated twice with measles-mumps-rubella vaccine (67.7%). Nearly half (46.6%) of cases occurred in university students or in persons with student contacts. Receipt of 2 doses of vaccine reduced the risk for orchitis, the most frequently reported complication (vaccine effectiveness [VE] 74%, 95% CI 57%–85%); complications overall (VE 76%, 95% CI 61%–86%); and hospitalization (VE 82%, 95% CI 53%–93%). Over time, the age distribution of case-patients changed, and proportionally more cases were reported from nonuniversity cities (p<0.001). Changes in age and geographic distribution over time may reflect increased immunity among students resulting from intense exposure to circulating mumps virus.

        Cite This Article
    EID Sane J, Gouma S, Koopmans M, de Melker H, Swaan C, van Binnendijk R, et al. Epidemic of Mumps among Vaccinated Persons, the Netherlands, 2009–2012. Emerg Infect Dis. 2014;20(4):643-648. https://dx.doi.org/10.3201/eid2004.131681
    AMA Sane J, Gouma S, Koopmans M, et al. Epidemic of Mumps among Vaccinated Persons, the Netherlands, 2009–2012. Emerging Infectious Diseases. 2014;20(4):643-648. doi:10.3201/eid2004.131681.
    APA Sane, J., Gouma, S., Koopmans, M., de Melker, H., Swaan, C., van Binnendijk, R....Hahné, S. (2014). Epidemic of Mumps among Vaccinated Persons, the Netherlands, 2009–2012. Emerging Infectious Diseases, 20(4), 643-648. https://dx.doi.org/10.3201/eid2004.131681.
  • Rapid Increase in Pertactin-deficient Bordetella pertussis Isolates, Australia PDF Version [PDF - 566 KB - 8 pages]
    C. Lam et al.
    View Summary

    This pattern is consistent with continuing evolution in response to vaccine selection pressure.

        View Abstract

    Acellular vaccines against Bordetella pertussis were introduced in Australia in 1997. By 2000, these vaccines had replaced whole-cell vaccines. During 2008–2012, a large outbreak of pertussis occurred. During this period, 30% (96/320) of B. pertussis isolates did not express the vaccine antigen pertactin (prn). Multiple mechanisms of prn inactivation were documented, including IS481 and IS1002 disruptions, a variation within a homopolymeric tract, and deletion of the prn gene. The mechanism of lack of expression of prn in 16 (17%) isolates could not be determined at the sequence level. These findings suggest that B. pertussis not expressing prn arose independently multiple times since 2008, rather than by expansion of a single prn-negative clone. All but 1 isolate had ptxA1, prn2, and ptxP3, the alleles representative of currently circulating strains in Australia. This pattern is consistent with continuing evolution of B. pertussis in response to vaccine selection pressure.

        Cite This Article
    EID Lam C, Octavia S, Ricafort L, Sintchenko V, Gilbert GL, Wood N, et al. Rapid Increase in Pertactin-deficient Bordetella pertussis Isolates, Australia. Emerg Infect Dis. 2014;20(4):626-633. https://dx.doi.org/10.3201/eid2004.131478
    AMA Lam C, Octavia S, Ricafort L, et al. Rapid Increase in Pertactin-deficient Bordetella pertussis Isolates, Australia. Emerging Infectious Diseases. 2014;20(4):626-633. doi:10.3201/eid2004.131478.
    APA Lam, C., Octavia, S., Ricafort, L., Sintchenko, V., Gilbert, G. L., Wood, N....Lan, R. (2014). Rapid Increase in Pertactin-deficient Bordetella pertussis Isolates, Australia. Emerging Infectious Diseases, 20(4), 626-633. https://dx.doi.org/10.3201/eid2004.131478.
  • Underdiagnosis of Foodborne Hepatitis A, the Netherlands, 2008–2010 PDF Version [PDF - 380 KB - 7 pages]
    M. Petrignani et al.
    View Summary

    Routine typing of virus from serum from reported patients is useful for detection of foodborne outbreaks.

        View Abstract

    Outbreaks of foodborne hepatitis A are rarely recognized as such. Detection of these infections is challenging because of the infection’s long incubation period and patients’ recall bias. Nevertheless, the complex food market might lead to reemergence of hepatitis A virus outside of disease-endemic areas. To assess the role of food as a source of infection, we combined routine surveillance with real-time strain sequencing in the Netherlands during 2008–2010. Virus RNA from serum of 248 (59%) of 421 reported case-patients could be sequenced. Without typing, foodborne transmission was suspected for only 4% of reported case-patients. With typing, foodborne transmission increased to being the most probable source of infection for 16%. We recommend routine implementation of an enhanced surveillance system that includes prompt forwarding and typing of hepatitis A virus RNA isolated from serum, standard use of questionnaires, data sharing, and centralized interpretation of data.

        Cite This Article
    EID Petrignani M, Verhoef L, Vennema H, van Hunen R, Baas D, van Steenbergen JE, et al. Underdiagnosis of Foodborne Hepatitis A, the Netherlands, 2008–2010. Emerg Infect Dis. 2014;20(4):596-602. https://dx.doi.org/10.3201/eid2004.130753
    AMA Petrignani M, Verhoef L, Vennema H, et al. Underdiagnosis of Foodborne Hepatitis A, the Netherlands, 2008–2010. Emerging Infectious Diseases. 2014;20(4):596-602. doi:10.3201/eid2004.130753.
    APA Petrignani, M., Verhoef, L., Vennema, H., van Hunen, R., Baas, D., van Steenbergen, J. E....Koopmans, M. (2014). Underdiagnosis of Foodborne Hepatitis A, the Netherlands, 2008–2010. Emerging Infectious Diseases, 20(4), 596-602. https://dx.doi.org/10.3201/eid2004.130753.
  • Regional Variation in Travel-related Illness acquired in Africa, March 1997–May 2011 PDF Version [PDF - 558 KB - 10 pages]
    M. Mendelson et al.
    View Summary

    Travel-related illness acquired in Africa varies markedly by the geographic region visited on the continent.

        View Abstract

    To understand geographic variation in travel-related illness acquired in distinct African regions, we used the GeoSentinel Surveillance Network database to analyze records for 16,893 ill travelers returning from Africa over a 14-year period. Travelers to northern Africa most commonly reported gastrointestinal illnesses and dog bites. Febrile illnesses were more common in travelers returning from sub-Saharan countries. Eleven travelers died, 9 of malaria; these deaths occurred mainly among male business travelers to sub-Saharan Africa. The profile of illness varied substantially by region: malaria predominated in travelers returning from Central and Western Africa; schistosomiasis, strongyloidiasis, and dengue from Eastern and Western Africa; and loaisis from Central Africa. There were few reports of vaccine-preventable infections, HIV infection, and tuberculosis. Geographic profiling of illness acquired during travel to Africa guides targeted pretravel advice, expedites diagnosis in ill returning travelers, and may influence destination choices in tourism.

        Cite This Article
    EID Mendelson M, Han PV, Vincent P, von Sonnenburg F, Cramer JP, Loutan L, et al. Regional Variation in Travel-related Illness acquired in Africa, March 1997–May 2011. Emerg Infect Dis. 2014;20(4):532-541. https://dx.doi.org/10.3201/eid2004.131128
    AMA Mendelson M, Han PV, Vincent P, et al. Regional Variation in Travel-related Illness acquired in Africa, March 1997–May 2011. Emerging Infectious Diseases. 2014;20(4):532-541. doi:10.3201/eid2004.131128.
    APA Mendelson, M., Han, P. V., Vincent, P., von Sonnenburg, F., Cramer, J. P., Loutan, L....Schlagenhauf, P. (2014). Regional Variation in Travel-related Illness acquired in Africa, March 1997–May 2011. Emerging Infectious Diseases, 20(4), 532-541. https://dx.doi.org/10.3201/eid2004.131128.
  • Large Outbreak of Cryptosporidium hominis Infection Transmitted through the Public Water Supply, Sweden PDF Version [PDF - 1.03 MB - 9 pages]
    M. Widerström et al.
    View Summary

    Use of inadequate microbial barriers at water treatment plants can have serious public health consequences.

        View Abstract

    In November 2010, ≈27,000 (≈45%) inhabitants of Östersund, Sweden, were affected by a waterborne outbreak of cryptosporidiosis. The outbreak was characterized by a rapid onset and high attack rate, especially among young and middle-aged persons. Young age, number of infected family members, amount of water consumed daily, and gluten intolerance were identified as risk factors for acquiring cryptosporidiosis. Also, chronic intestinal disease and young age were significantly associated with prolonged diarrhea. Identification of Cryptosporidium hominis subtype IbA10G2 in human and environmental samples and consistently low numbers of oocysts in drinking water confirmed insufficient reduction of parasites by the municipal water treatment plant. The current outbreak shows that use of inadequate microbial barriers at water treatment plants can have serious consequences for public health. This risk can be minimized by optimizing control of raw water quality and employing multiple barriers that remove or inactivate all groups of pathogens.

        Cite This Article
    EID Widerström M, Schönning C, Lilja M, Lebbad M, Ljung T, Allestam G, et al. Large Outbreak of Cryptosporidium hominis Infection Transmitted through the Public Water Supply, Sweden. Emerg Infect Dis. 2014;20(4):581-589. https://dx.doi.org/10.3201/eid2004.121415
    AMA Widerström M, Schönning C, Lilja M, et al. Large Outbreak of Cryptosporidium hominis Infection Transmitted through the Public Water Supply, Sweden. Emerging Infectious Diseases. 2014;20(4):581-589. doi:10.3201/eid2004.121415.
    APA Widerström, M., Schönning, C., Lilja, M., Lebbad, M., Ljung, T., Allestam, G....Lindh, J. (2014). Large Outbreak of Cryptosporidium hominis Infection Transmitted through the Public Water Supply, Sweden. Emerging Infectious Diseases, 20(4), 581-589. https://dx.doi.org/10.3201/eid2004.121415.
  • Gnathostoma spinigerum in Live Asian Swamp Eels (Monopterus spp.) from Food Markets and Wild Populations, United States PDF Version [PDF - 642 KB - 9 pages]
    R. A. Cole et al.
    View Summary

    Imported live eels are a potential source of human gnathostomiasis.

        View Abstract

    In Southeast Asia, swamp eels (Synbranchidae: Monopterus spp.) are a common source of human gnathostomiasis, a foodborne zoonosis caused by advanced third-stage larvae (AL3) of Gnathostoma spp. nematodes. Live Asian swamp eels are imported to US ethnic food markets, and wild populations exist in several states. To determine whether these eels are infected, we examined 47 eels from markets and 67 wild-caught specimens. Nematodes were identified by morphologic features and ribosomal intergenic transcribed spacer–2 gene sequencing. Thirteen (27.7%) M. cuchia eels from markets were infected with 36 live G. spinigerum AL3: 21 (58.3%) in liver; 7 (19.4%) in muscle; 5 (13.8%) in gastrointestinal tract, and 3 (8.3%) in kidneys. Three (4.5%) wild-caught M. albus eels were infected with 5 G. turgidum AL3 in muscle, and 1 G. lamothei AL3 was found in a kidney (both North American spp.). Imported live eels are a potential source of human gnathostomiasis in the United States.

        Cite This Article
    EID Cole RA, Choudhury A, Nico LG, Griffin KM. Gnathostoma spinigerum in Live Asian Swamp Eels (Monopterus spp.) from Food Markets and Wild Populations, United States. Emerg Infect Dis. 2014;20(4):634-642. https://dx.doi.org/10.3201/eid2004.131566
    AMA Cole RA, Choudhury A, Nico LG, et al. Gnathostoma spinigerum in Live Asian Swamp Eels (Monopterus spp.) from Food Markets and Wild Populations, United States. Emerging Infectious Diseases. 2014;20(4):634-642. doi:10.3201/eid2004.131566.
    APA Cole, R. A., Choudhury, A., Nico, L. G., & Griffin, K. M. (2014). Gnathostoma spinigerum in Live Asian Swamp Eels (Monopterus spp.) from Food Markets and Wild Populations, United States. Emerging Infectious Diseases, 20(4), 634-642. https://dx.doi.org/10.3201/eid2004.131566.
  • Medscape CME Activity
    Travel-associated Antimicrobial Drug–Resistant Nontyphoidal Salmonellae, 2004–2009 PDF Version [PDF - 669 KB - 9 pages]
    R. S. Barlow et al.
    View Summary

    Providers should evaluate patient travel history and bacterial serotype when considering antimicrobial therapy.

        View Abstract

    To evaluate trends in and risk factors for acquisition of antimicrobial-drug resistant nontyphoidal Salmonella infections, we searched Oregon surveillance data for 2004–2009 for all culture-confirmed cases of salmonellosis. We defined clinically important resistance (CIR) as decreased susceptibility to ampicillin, ceftriaxone, ciprofloxacin, gentamicin, or trimethoprim/sulfamethoxazole. Of 2,153 cases, 2,127 (99%) nontyphoidal Salmonella isolates were obtained from a specific source (e.g., feces, urine, blood, or other normally sterile tissue) and had been tested for drug susceptibility. Among these, 347 (16%) isolates had CIR. The odds of acquiring CIR infection significantly increased each year. Hospitalization was more likely for patients with than without CIR infections. Among patients with isolates that had been tested, we analyzed data from 1,813 (84%) who were interviewed. Travel to eastern or Southeast Asia was associated with increased CIR. Isolates associated with outbreaks were less likely to have CIR. Future surveillance activities should evaluate resistance with respect to international travel.

        Cite This Article
    EID Barlow RS, DeBess EE, Winthrop KL, Lapidus JA, Vega R, Cieslak PR, et al. Travel-associated Antimicrobial Drug–Resistant Nontyphoidal Salmonellae, 2004–2009. Emerg Infect Dis. 2014;20(4):603-611. https://dx.doi.org/10.3201/eid2004.131063
    AMA Barlow RS, DeBess EE, Winthrop KL, et al. Travel-associated Antimicrobial Drug–Resistant Nontyphoidal Salmonellae, 2004–2009. Emerging Infectious Diseases. 2014;20(4):603-611. doi:10.3201/eid2004.131063.
    APA Barlow, R. S., DeBess, E. E., Winthrop, K. L., Lapidus, J. A., Vega, R., & Cieslak, P. R. (2014). Travel-associated Antimicrobial Drug–Resistant Nontyphoidal Salmonellae, 2004–2009. Emerging Infectious Diseases, 20(4), 603-611. https://dx.doi.org/10.3201/eid2004.131063.
  • Rotavirus Surveillance in Urban and Rural Areas of Niger, April 2010–March 2012 PDF Version [PDF - 460 KB - 8 pages]
    A. Page et al.
    View Summary

    The emergence of G12P[8] warrants close attention to the characteristics of associated epidemics and possible prevention measures.

        View Abstract

    Knowledge of rotavirus epidemiology is necessary to make informed decisions about vaccine introduction and to evaluate vaccine impact. During April 2010–March 2012, rotavirus surveillance was conducted among 9,745 children <5 years of age in 14 hospitals/health centers in Niger, where rotavirus vaccine has not been introduced. Study participants had acute watery diarrhea and moderate to severe dehydration, and 20% of the children were enrolled in a nutrition program. Of the 9,745 children, 30.6% were rotavirus positive. Genotyping of a subset of positive samples showed a variety of genotypes during the first year, although G2P[4] predominated. G12 genotypes, including G12P[8], which has emerged as a predominant strain in western Africa, represented >80% of isolates during the second year. Hospitalization and death rates and severe dehydration among rotavirus case-patients did not differ during the 2 years. The emergence of G12P[8] warrants close attention to the characteristics of associated epidemics and possible prevention measures.

        Cite This Article
    EID Page A, Jusot V, Mamaty A, Adamou L, Kaplon J, Pothier P, et al. Rotavirus Surveillance in Urban and Rural Areas of Niger, April 2010–March 2012. Emerg Infect Dis. 2014;20(4):573-580. https://dx.doi.org/10.3201/eid2004.131328
    AMA Page A, Jusot V, Mamaty A, et al. Rotavirus Surveillance in Urban and Rural Areas of Niger, April 2010–March 2012. Emerging Infectious Diseases. 2014;20(4):573-580. doi:10.3201/eid2004.131328.
    APA Page, A., Jusot, V., Mamaty, A., Adamou, L., Kaplon, J., Pothier, P....Grais, R. F. (2014). Rotavirus Surveillance in Urban and Rural Areas of Niger, April 2010–March 2012. Emerging Infectious Diseases, 20(4), 573-580. https://dx.doi.org/10.3201/eid2004.131328.
  • Novel Betacoronavirus in Dromedaries of the Middle East, 2013 PDF Version [PDF - 749 KB - 13 pages]
    P. Woo et al.
    View Summary

    Continuous surveillance is needed to understand the potential for virus emergence in camels and subsequent transmission to humans.

        View Abstract

    In 2013, a novel betacoronavirus was identified in fecal samples from dromedaries in Dubai, United Arab Emirates. Antibodies against the recombinant nucleocapsid protein of the virus, which we named dromedary camel coronavirus (DcCoV) UAE-HKU23, were detected in 52% of 59 dromedary serum samples tested. In an analysis of 3 complete DcCoV UAE-HKU23 genomes, we identified the virus as a betacoronavirus in lineage A1. The DcCoV UAE-HKU23 genome has G+C contents; a general preference for G/C in the third position of codons; a cleavage site for spike protein; and a membrane protein of similar length to that of other betacoronavirus A1 members, to which DcCoV UAE-HKU23 is phylogenetically closely related. Along with this coronavirus, viruses of at least 8 other families have been found to infect camels. Because camels have a close association with humans, continuous surveillance should be conducted to understand the potential for virus emergence in camels and for virus transmission to humans.

        Cite This Article
    EID Woo P, Lau S, Wernery U, Wong E, Tsang A, Johnson B, et al. Novel Betacoronavirus in Dromedaries of the Middle East, 2013. Emerg Infect Dis. 2014;20(4):560-572. https://dx.doi.org/10.3201/eid2004.131769
    AMA Woo P, Lau S, Wernery U, et al. Novel Betacoronavirus in Dromedaries of the Middle East, 2013. Emerging Infectious Diseases. 2014;20(4):560-572. doi:10.3201/eid2004.131769.
    APA Woo, P., Lau, S., Wernery, U., Wong, E., Tsang, A., Johnson, B....Yuen, K. (2014). Novel Betacoronavirus in Dromedaries of the Middle East, 2013. Emerging Infectious Diseases, 20(4), 560-572. https://dx.doi.org/10.3201/eid2004.131769.
  • High Rates of Antimicrobial Drug Resistance Gene Acquisition after International Travel, the Netherlands PDF Version [PDF - 1.23 MB - 9 pages]
    C. von Wintersdorff et al.
    View Summary

    The metagenomic approach used might detect resistance genes in more species than culturing bacteria does.

        View Abstract

    We investigated the effect of international travel on the gut resistome of 122 healthy travelers from the Netherlands by using a targeted metagenomic approach. Our results confirm high acquisition rates of the extended-spectrum β-lactamase encoding gene blaCTX-M, documenting a rise in prevalence from 9.0% before travel to 33.6% after travel (p<0.001). The prevalence of quinolone resistance encoding genes qnrB and qnrS increased from 6.6% and 8.2% before travel to 36.9% and 55.7% after travel, respectively (both p<0.001). Travel to Southeast Asia and the Indian subcontinent was associated with the highest acquisition rates of qnrS and both blaCTX-M and qnrS, respectively. Investigation of the associations between the acquisitions of the blaCTX-M and qnr genes showed that acquisition of a blaCTX-M gene was not associated with that of a qnrB (p = 0.305) or qnrS (p = 0.080) gene. These findings support the increasing evidence that travelers contribute to the spread of antimicrobial drug resistance.

        Cite This Article
    EID von Wintersdorff C, Penders J, Stobberingh EE, Lashof A, Hoebe C, Savelkoul P, et al. High Rates of Antimicrobial Drug Resistance Gene Acquisition after International Travel, the Netherlands. Emerg Infect Dis. 2014;20(4):649-657. https://dx.doi.org/10.3201/eid2004.131718
    AMA von Wintersdorff C, Penders J, Stobberingh EE, et al. High Rates of Antimicrobial Drug Resistance Gene Acquisition after International Travel, the Netherlands. Emerging Infectious Diseases. 2014;20(4):649-657. doi:10.3201/eid2004.131718.
    APA von Wintersdorff, C., Penders, J., Stobberingh, E. E., Lashof, A., Hoebe, C., Savelkoul, P....Wolffs, P. (2014). High Rates of Antimicrobial Drug Resistance Gene Acquisition after International Travel, the Netherlands. Emerging Infectious Diseases, 20(4), 649-657. https://dx.doi.org/10.3201/eid2004.131718.

Dispatches

  • Spread of Virulent Group A Streptococcus Type emm59 from Montana to Wyoming, USA PDF Version [PDF - 286 KB - 3 pages]
    C. C. Brown et al.
        View Abstract

    Full-genome sequencing showed that a recently emerged and hypervirulent clone of group A Streptococcus type emm59 active in Canada and parts of the United States has now caused severe invasive infections in rural northeastern Wyoming. Phylogenetic analysis of genome data indicated that the strain was likely introduced from Montana.

        Cite This Article
    EID Brown CC, Olsen RJ, Fittipaldi N, Morman ML, Fort PL, Neuwirth R, et al. Spread of Virulent Group A Streptococcus Type emm59 from Montana to Wyoming, USA. Emerg Infect Dis. 2014;20(4):658-660. https://dx.doi.org/10.3201/eid2004.130564
    AMA Brown CC, Olsen RJ, Fittipaldi N, et al. Spread of Virulent Group A Streptococcus Type emm59 from Montana to Wyoming, USA. Emerging Infectious Diseases. 2014;20(4):658-660. doi:10.3201/eid2004.130564.
    APA Brown, C. C., Olsen, R. J., Fittipaldi, N., Morman, M. L., Fort, P. L., Neuwirth, R....Musser, J. M. (2014). Spread of Virulent Group A Streptococcus Type emm59 from Montana to Wyoming, USA. Emerging Infectious Diseases, 20(4), 658-660. https://dx.doi.org/10.3201/eid2004.130564.
  • Burkholderia pseudomallei Type G in Western Hemisphere PDF Version [PDF - 468 KB - 3 pages]
    J. E. Gee et al.
        View Abstract

    Burkholderia pseudomallei isolates from the Western Hemisphere are difficult to differentiate from those from regions in which melioidosis is traditionally endemic. We used internal transcribed spacer typing to determine that B. pseudomallei isolates from the Western Hemisphere are consistently type G. Knowledge of this relationship might be useful for epidemiologic investigations.

        Cite This Article
    EID Gee JE, Allender CJ, Tuanyok A, Elrod MG, Hoffmaster AR. Burkholderia pseudomallei Type G in Western Hemisphere. Emerg Infect Dis. 2014;20(4):661-663. https://dx.doi.org/10.3201/eid2004.130960
    AMA Gee JE, Allender CJ, Tuanyok A, et al. Burkholderia pseudomallei Type G in Western Hemisphere. Emerging Infectious Diseases. 2014;20(4):661-663. doi:10.3201/eid2004.130960.
    APA Gee, J. E., Allender, C. J., Tuanyok, A., Elrod, M. G., & Hoffmaster, A. R. (2014). Burkholderia pseudomallei Type G in Western Hemisphere. Emerging Infectious Diseases, 20(4), 661-663. https://dx.doi.org/10.3201/eid2004.130960.
  • Invasive Salmonella enterica Serotype Typhimurium Infections, Democratic Republic of the Congo, 2007–2011 PDF Version [PDF - 419 KB - 4 pages]
    B. Ley et al.
        View Abstract

    Infection with Salmonella enterica serotype Typhimurium sequence type (ST) 313 is associated with high rates of drug resistance, bloodstream infections, and death. To determine whether ST313 is dominant in the Democratic Republic of the Congo, we studied 180 isolates collected during 2007–2011; 96% belonged to CRISPOL type CT28, which is associated with ST313.

        Cite This Article
    EID Ley B, Le Hello S, Lunguya O, Lejon V, Muyembe J, Weill F, et al. Invasive Salmonella enterica Serotype Typhimurium Infections, Democratic Republic of the Congo, 2007–2011. Emerg Infect Dis. 2014;20(4):701-704. https://dx.doi.org/10.3201/eid2004.131488
    AMA Ley B, Le Hello S, Lunguya O, et al. Invasive Salmonella enterica Serotype Typhimurium Infections, Democratic Republic of the Congo, 2007–2011. Emerging Infectious Diseases. 2014;20(4):701-704. doi:10.3201/eid2004.131488.
    APA Ley, B., Le Hello, S., Lunguya, O., Lejon, V., Muyembe, J., Weill, F....Jacobs, J. (2014). Invasive Salmonella enterica Serotype Typhimurium Infections, Democratic Republic of the Congo, 2007–2011. Emerging Infectious Diseases, 20(4), 701-704. https://dx.doi.org/10.3201/eid2004.131488.
  • Complete Genome of Hepatitis E Virus from Laboratory Ferrets PDF Version [PDF - 867 KB - 4 pages]
    T. Li et al.
        View Abstract

    The complete genome of hepatitis E virus (HEV) from laboratory ferrets imported from the United States was identified. This virus shared only 82.4%–82.5% nt sequence identities with strains from the Netherlands, which indicated that the ferret HEV genome is genetically diverse. Some laboratory ferrets were contaminated with HEV.

        Cite This Article
    EID Li T, Yang T, Ami Y, Suzaki Y, Shirakura M, Kishida N, et al. Complete Genome of Hepatitis E Virus from Laboratory Ferrets. Emerg Infect Dis. 2014;20(4):709-712. https://dx.doi.org/10.3201/eid2004.131815
    AMA Li T, Yang T, Ami Y, et al. Complete Genome of Hepatitis E Virus from Laboratory Ferrets. Emerging Infectious Diseases. 2014;20(4):709-712. doi:10.3201/eid2004.131815.
    APA Li, T., Yang, T., Ami, Y., Suzaki, Y., Shirakura, M., Kishida, N....Takaji, W. (2014). Complete Genome of Hepatitis E Virus from Laboratory Ferrets. Emerging Infectious Diseases, 20(4), 709-712. https://dx.doi.org/10.3201/eid2004.131815.
  • New Alphacoronavirus in Mystacina tuberculata Bats, New Zealand PDF Version [PDF - 541 KB - 4 pages]
    R. J. Hall et al.
        View Abstract

    Because of recent interest in bats as reservoirs of emerging diseases, we investigated the presence of viruses in Mystacina tuberculata bats in New Zealand. A novel alphacoronavirus sequence was detected in guano from roosts of M. tuberculata bats in pristine indigenous forest on a remote offshore island (Codfish Island).

        Cite This Article
    EID Hall RJ, Wang J, Peacey M, Moore NE, McInnes K, Tompkins DM, et al. New Alphacoronavirus in Mystacina tuberculata Bats, New Zealand. Emerg Infect Dis. 2014;20(4):697-700. https://dx.doi.org/10.3201/eid2004.131441
    AMA Hall RJ, Wang J, Peacey M, et al. New Alphacoronavirus in Mystacina tuberculata Bats, New Zealand. Emerging Infectious Diseases. 2014;20(4):697-700. doi:10.3201/eid2004.131441.
    APA Hall, R. J., Wang, J., Peacey, M., Moore, N. E., McInnes, K., & Tompkins, D. M. (2014). New Alphacoronavirus in Mystacina tuberculata Bats, New Zealand. Emerging Infectious Diseases, 20(4), 697-700. https://dx.doi.org/10.3201/eid2004.131441.
  • Vibrio parahaemolyticus, Southern Coastal Region of China, 2007–2012 PDF Version [PDF - 390 KB - 4 pages]
    Y. Li et al.
        View Abstract

    We analyzed the prevalence and characteristics of Vibrio parahaemolyticus among patients with acute infectious diarrhea in the southern coastal region of China. V. parahaemolyticus was the leading cause of bacterial infectious diarrhea in this region during 2007–2012. Serotype O3:K6 strains were most common, followed by serotypes O4:K8 and O3:K29.

        Cite This Article
    EID Li Y, Xie X, Shi X, Lin Y, Mou J, Chen Q, et al. Vibrio parahaemolyticus, Southern Coastal Region of China, 2007–2012. Emerg Infect Dis. 2014;20(4):685-688. https://dx.doi.org/10.3201/eid2004.130744
    AMA Li Y, Xie X, Shi X, et al. Vibrio parahaemolyticus, Southern Coastal Region of China, 2007–2012. Emerging Infectious Diseases. 2014;20(4):685-688. doi:10.3201/eid2004.130744.
    APA Li, Y., Xie, X., Shi, X., Lin, Y., Mou, J., Chen, Q....Hu, Q. (2014). Vibrio parahaemolyticus, Southern Coastal Region of China, 2007–2012. Emerging Infectious Diseases, 20(4), 685-688. https://dx.doi.org/10.3201/eid2004.130744.
  • Pathology of US Porcine Epidemic Diarrhea Virus Strain PC21A in Gnotobiotic Pigs PDF Version [PDF - 386 KB - 4 pages]
    K. Jung et al.
        View Abstract

    To understand the progression of porcine epidemic diarrhea virus infection, we inoculated gnotobiotic pigs with a newly emerged US strain, PC21A, of the virus. At 24–48 hours postinoculation, the pigs exhibited severe diarrhea and vomiting, fecal shedding, viremia, and severe atrophic enteritis. These findings confirm that strain PC21A is highly enteropathogenic.

        Cite This Article
    EID Jung K, Wang Q, Scheuer KA, Lu Z, Zhang Y, Saif LJ, et al. Pathology of US Porcine Epidemic Diarrhea Virus Strain PC21A in Gnotobiotic Pigs. Emerg Infect Dis. 2014;20(4):668-671. https://dx.doi.org/10.3201/eid2004.131685
    AMA Jung K, Wang Q, Scheuer KA, et al. Pathology of US Porcine Epidemic Diarrhea Virus Strain PC21A in Gnotobiotic Pigs. Emerging Infectious Diseases. 2014;20(4):668-671. doi:10.3201/eid2004.131685.
    APA Jung, K., Wang, Q., Scheuer, K. A., Lu, Z., Zhang, Y., & Saif, L. J. (2014). Pathology of US Porcine Epidemic Diarrhea Virus Strain PC21A in Gnotobiotic Pigs. Emerging Infectious Diseases, 20(4), 668-671. https://dx.doi.org/10.3201/eid2004.131685.
  • Cetacean Morbillivirus in Coastal Indo-Pacific Bottlenose Dolphins, Western Australia PDF Version [PDF - 614 KB - 5 pages]
    N. Stephens et al.
        View Abstract

    Cetacean morbillivirus (CeMV) has caused several epizootics in multiple species of cetaceans globally and is an emerging disease among cetaceans in Australia. We detected CeMV in 2 stranded coastal Indo-Pacific bottlenose dolphins (Tursiops aduncus) in Western Australia. Preliminary phylogenetic data suggest that this virus variant is divergent from known strains.

        Cite This Article
    EID Stephens N, Duignan PJ, Wang J, Bingham J, Finn H, Bejder L, et al. Cetacean Morbillivirus in Coastal Indo-Pacific Bottlenose Dolphins, Western Australia. Emerg Infect Dis. 2014;20(4):672-676. https://dx.doi.org/10.3201/eid2004.131714
    AMA Stephens N, Duignan PJ, Wang J, et al. Cetacean Morbillivirus in Coastal Indo-Pacific Bottlenose Dolphins, Western Australia. Emerging Infectious Diseases. 2014;20(4):672-676. doi:10.3201/eid2004.131714.
    APA Stephens, N., Duignan, P. J., Wang, J., Bingham, J., Finn, H., Bejder, L....Holyoake, C. (2014). Cetacean Morbillivirus in Coastal Indo-Pacific Bottlenose Dolphins, Western Australia. Emerging Infectious Diseases, 20(4), 672-676. https://dx.doi.org/10.3201/eid2004.131714.
  • Hepatitis E Antibodies in Laboratory Rabbits from 2 US Vendors PDF Version [PDF - 550 KB - 4 pages]
    L. Birke et al.
        View Abstract

    We tested laboratory rabbits from 2 US vendors for antibodies against hepatitis E virus (HEV); Seroprevalences were 40% and 50%. Retrospective analysis of an ocular herpes simplex 1 experiment demonstrated that HEV seropositivity had no effect on experiment outcome. HEV probably is widespread in research rabbits, but effects on research remain unknown.

        Cite This Article
    EID Birke L, Cormier SA, You D, Stout RW, Clement C, Johnson M, et al. Hepatitis E Antibodies in Laboratory Rabbits from 2 US Vendors. Emerg Infect Dis. 2014;20(4):693-696. https://dx.doi.org/10.3201/eid2004.131229
    AMA Birke L, Cormier SA, You D, et al. Hepatitis E Antibodies in Laboratory Rabbits from 2 US Vendors. Emerging Infectious Diseases. 2014;20(4):693-696. doi:10.3201/eid2004.131229.
    APA Birke, L., Cormier, S. A., You, D., Stout, R. W., Clement, C., Johnson, M....Thompson, H. (2014). Hepatitis E Antibodies in Laboratory Rabbits from 2 US Vendors. Emerging Infectious Diseases, 20(4), 693-696. https://dx.doi.org/10.3201/eid2004.131229.
  • Clinical Malaria along the China–Myanmar Border, Yunnan Province, China, January 2011–August 2012 PDF Version [PDF - 432 KB - 4 pages]
    G. Zhou et al.
        View Abstract

    Passive surveillance for malaria cases was conducted in Yunnan Province, China, along the China–Myanmar border. Infection with Plasmodium vivax and P. falciparum protozoa accounted for 69% and 28% of the cases, respectively. Most patients were adult men. Cross-border travel into Myanmar was a key risk factor for P. falciparum malaria in China.

        Cite This Article
    EID Zhou G, Sun L, Xia R, Duan Y, Xu J, Yang H, et al. Clinical Malaria along the China–Myanmar Border, Yunnan Province, China, January 2011–August 2012. Emerg Infect Dis. 2014;20(4):681-684. https://dx.doi.org/10.3201/eid2004.130647
    AMA Zhou G, Sun L, Xia R, et al. Clinical Malaria along the China–Myanmar Border, Yunnan Province, China, January 2011–August 2012. Emerging Infectious Diseases. 2014;20(4):681-684. doi:10.3201/eid2004.130647.
    APA Zhou, G., Sun, L., Xia, R., Duan, Y., Xu, J., Yang, H....Yang, Z. (2014). Clinical Malaria along the China–Myanmar Border, Yunnan Province, China, January 2011–August 2012. Emerging Infectious Diseases, 20(4), 681-684. https://dx.doi.org/10.3201/eid2004.130647.
  • Characteristics of Patients Infected with Norovirus GII.4 Sydney 2012, Hong Kong, China PDF Version [PDF - 479 KB - 4 pages]
    M. Chan et al.
        View Abstract

    Norovirus GII.4 Sydney 2012 has spread globally since late 2012. We report hospitalization of patients infected with this strain skewed toward infants and young children among 174 cases during August 2012–July 2013 in Hong Kong, China. This group had higher fecal viral load (≈10-fold) than did older children and adults.

        Cite This Article
    EID Chan M, Leung TF, Kwok AK, Lee N, Chan P. Characteristics of Patients Infected with Norovirus GII.4 Sydney 2012, Hong Kong, China. Emerg Infect Dis. 2014;20(4):664-667. https://dx.doi.org/10.3201/eid2004.131457
    AMA Chan M, Leung TF, Kwok AK, et al. Characteristics of Patients Infected with Norovirus GII.4 Sydney 2012, Hong Kong, China. Emerging Infectious Diseases. 2014;20(4):664-667. doi:10.3201/eid2004.131457.
    APA Chan, M., Leung, T. F., Kwok, A. K., Lee, N., & Chan, P. (2014). Characteristics of Patients Infected with Norovirus GII.4 Sydney 2012, Hong Kong, China. Emerging Infectious Diseases, 20(4), 664-667. https://dx.doi.org/10.3201/eid2004.131457.
  • Salmonella Subtypes with Increased MICs for Azithromycin in Travelers Returned to the Netherlands PDF Version [PDF - 394 KB - 4 pages]
    R. Hassing et al.
        View Abstract

    Antimicrobial susceptibility was analyzed for 354 typhoidal Salmonella isolates collected during 1999–2012 in the Netherlands. In 16.1% of all isolates and in 23.8% of all isolates that showed increased MICs for ciprofloxacin, the MIC for azithromycin was increased. This resistance may complicate empirical treatment of enteric fever.

        Cite This Article
    EID Hassing R, Goessens W, van Pelt W, Mevius DJ, Stricker BH, Molhoek N, et al. Salmonella Subtypes with Increased MICs for Azithromycin in Travelers Returned to the Netherlands. Emerg Infect Dis. 2014;20(4):705-708. https://dx.doi.org/10.3201/eid2004.131536
    AMA Hassing R, Goessens W, van Pelt W, et al. Salmonella Subtypes with Increased MICs for Azithromycin in Travelers Returned to the Netherlands. Emerging Infectious Diseases. 2014;20(4):705-708. doi:10.3201/eid2004.131536.
    APA Hassing, R., Goessens, W., van Pelt, W., Mevius, D. J., Stricker, B. H., Molhoek, N....van Genderen, P. (2014). Salmonella Subtypes with Increased MICs for Azithromycin in Travelers Returned to the Netherlands. Emerging Infectious Diseases, 20(4), 705-708. https://dx.doi.org/10.3201/eid2004.131536.
  • Diagnostic Methods for and Clinical Pictures of Polyomavirus Primary Infections in Children, Finland PDF Version [PDF - 351 KB - 4 pages]
    T. Chen et al.
        View Abstract

    We used comprehensive serodiagnostic methods (IgM, IgG, and IgG avidity) and PCR to study Merkel cell polyomavirus and trichodysplasia spinulosa-associated polyomavirus infections in children observed from infancy to adolescence. Comparing seroconversion intervals with previous and subsequent intervals, we found that primary infections with these 2 viruses were asymptomatic in childhood.

        Cite This Article
    EID Chen T, Tanner L, Simell V, Hedman L, Mäkinen M, Sadeghi M, et al. Diagnostic Methods for and Clinical Pictures of Polyomavirus Primary Infections in Children, Finland. Emerg Infect Dis. 2014;20(4):689-692. https://dx.doi.org/10.3201/eid2004.131015
    AMA Chen T, Tanner L, Simell V, et al. Diagnostic Methods for and Clinical Pictures of Polyomavirus Primary Infections in Children, Finland. Emerging Infectious Diseases. 2014;20(4):689-692. doi:10.3201/eid2004.131015.
    APA Chen, T., Tanner, L., Simell, V., Hedman, L., Mäkinen, M., Sadeghi, M....Hedman, K. (2014). Diagnostic Methods for and Clinical Pictures of Polyomavirus Primary Infections in Children, Finland. Emerging Infectious Diseases, 20(4), 689-692. https://dx.doi.org/10.3201/eid2004.131015.
  • Genetic Characterization of Clade 2.3.2.1 Avian Influenza A(H5N1) Viruses, Indonesia, 2012 PDF Version [PDF - 518 KB - 4 pages]
    N. Dharmayanti et al.
        View Abstract

    After reports of unusually high mortality rates among ducks on farms in Java Island, Indonesia, in September 2012, influenza A(H5N1) viruses were detected and characterized. Sequence analyses revealed all genes clustered with contemporary clade 2.3.2.1 viruses, rather than enzootic clade 2.1.3 viruses, indicating the introduction of an exotic H5N1 clade into Indonesia.

        Cite This Article
    EID Dharmayanti N, Hartawan R, Pudjiatmoko, Wibawa H, Hardiman, Balish A, et al. Genetic Characterization of Clade 2.3.2.1 Avian Influenza A(H5N1) Viruses, Indonesia, 2012. Emerg Infect Dis. 2014;20(4):671-674. https://dx.doi.org/10.3201/eid2004.130517
    AMA Dharmayanti N, Hartawan R, Pudjiatmoko, et al. Genetic Characterization of Clade 2.3.2.1 Avian Influenza A(H5N1) Viruses, Indonesia, 2012. Emerging Infectious Diseases. 2014;20(4):671-674. doi:10.3201/eid2004.130517.
    APA Dharmayanti, N., Hartawan, R., Pudjiatmoko., Wibawa, H., Hardiman., Balish, A....Samaan, G. (2014). Genetic Characterization of Clade 2.3.2.1 Avian Influenza A(H5N1) Viruses, Indonesia, 2012. Emerging Infectious Diseases, 20(4), 671-674. https://dx.doi.org/10.3201/eid2004.130517.

Commentaries

Letters

  • Decline of Salmonella enterica Serotype Choleraesuis Infections, Taiwan PDF Version [PDF - 311 KB - 2 pages]
    L. Su et al.
            Cite This Article
    EID Su L, Wu T, Chiu C. Decline of Salmonella enterica Serotype Choleraesuis Infections, Taiwan. Emerg Infect Dis. 2014;20(4):715-716. https://dx.doi.org/10.3201/eid2004.130240
    AMA Su L, Wu T, Chiu C. Decline of Salmonella enterica Serotype Choleraesuis Infections, Taiwan. Emerging Infectious Diseases. 2014;20(4):715-716. doi:10.3201/eid2004.130240.
    APA Su, L., Wu, T., & Chiu, C. (2014). Decline of Salmonella enterica Serotype Choleraesuis Infections, Taiwan. Emerging Infectious Diseases, 20(4), 715-716. https://dx.doi.org/10.3201/eid2004.130240.
  • Q Fever Endocarditis and New Coxiella burnetii Genotype, Saudi Arabia PDF Version [PDF - 307 KB - 3 pages]
    E. Angelakis et al.
            Cite This Article
    EID Angelakis E, Johani S, Ahsan A, Memish Z, Raoult D. Q Fever Endocarditis and New Coxiella burnetii Genotype, Saudi Arabia. Emerg Infect Dis. 2014;20(4):726-728. https://dx.doi.org/10.3201/eid2004.131603
    AMA Angelakis E, Johani S, Ahsan A, et al. Q Fever Endocarditis and New Coxiella burnetii Genotype, Saudi Arabia. Emerging Infectious Diseases. 2014;20(4):726-728. doi:10.3201/eid2004.131603.
    APA Angelakis, E., Johani, S., Ahsan, A., Memish, Z., & Raoult, D. (2014). Q Fever Endocarditis and New Coxiella burnetii Genotype, Saudi Arabia. Emerging Infectious Diseases, 20(4), 726-728. https://dx.doi.org/10.3201/eid2004.131603.
  • Nosocomial Drug-Resistant Bacteremia in 2 Cohorts with Cryptococcal Meningitis, Africa PDF Version [PDF - 283 KB - 3 pages]
    R. Rajasingham et al.
            Cite This Article
    EID Rajasingham R, Williams D, Meya DB, Meintjes G, Boulware DR, Scriven J, et al. Nosocomial Drug-Resistant Bacteremia in 2 Cohorts with Cryptococcal Meningitis, Africa. Emerg Infect Dis. 2014;20(4):722-724. https://dx.doi.org/10.3201/eid2004.131277
    AMA Rajasingham R, Williams D, Meya DB, et al. Nosocomial Drug-Resistant Bacteremia in 2 Cohorts with Cryptococcal Meningitis, Africa. Emerging Infectious Diseases. 2014;20(4):722-724. doi:10.3201/eid2004.131277.
    APA Rajasingham, R., Williams, D., Meya, D. B., Meintjes, G., Boulware, D. R., & Scriven, J. (2014). Nosocomial Drug-Resistant Bacteremia in 2 Cohorts with Cryptococcal Meningitis, Africa. Emerging Infectious Diseases, 20(4), 722-724. https://dx.doi.org/10.3201/eid2004.131277.
  • Detection of Rickettsia sibirica mongolitimonae by Using Cutaneous Swab Samples and Quantitative PCR PDF Version [PDF - 338 KB - 3 pages]
    J. Solary et al.
            Cite This Article
    EID Solary J, Socolovschi C, Aubry C, Brouqui P, Raoult D, Parola P, et al. Detection of Rickettsia sibirica mongolitimonae by Using Cutaneous Swab Samples and Quantitative PCR. Emerg Infect Dis. 2014;20(4):716-718. https://dx.doi.org/10.3201/eid2004.130575
    AMA Solary J, Socolovschi C, Aubry C, et al. Detection of Rickettsia sibirica mongolitimonae by Using Cutaneous Swab Samples and Quantitative PCR. Emerging Infectious Diseases. 2014;20(4):716-718. doi:10.3201/eid2004.130575.
    APA Solary, J., Socolovschi, C., Aubry, C., Brouqui, P., Raoult, D., & Parola, P. (2014). Detection of Rickettsia sibirica mongolitimonae by Using Cutaneous Swab Samples and Quantitative PCR. Emerging Infectious Diseases, 20(4), 716-718. https://dx.doi.org/10.3201/eid2004.130575.
  • Severe Babesiosis in Immunocompetent Man, Spain, 2011 PDF Version [PDF - 279 KB - 3 pages]
    L. M. Gonzalez et al.
            Cite This Article
    EID Gonzalez LM, Rojo S, Gonzalez-Camacho F, Luque D, Lobo CA, Montero E, et al. Severe Babesiosis in Immunocompetent Man, Spain, 2011. Emerg Infect Dis. 2014;20(4):724-726. https://dx.doi.org/10.3201/eid2004.131409
    AMA Gonzalez LM, Rojo S, Gonzalez-Camacho F, et al. Severe Babesiosis in Immunocompetent Man, Spain, 2011. Emerging Infectious Diseases. 2014;20(4):724-726. doi:10.3201/eid2004.131409.
    APA Gonzalez, L. M., Rojo, S., Gonzalez-Camacho, F., Luque, D., Lobo, C. A., & Montero, E. (2014). Severe Babesiosis in Immunocompetent Man, Spain, 2011. Emerging Infectious Diseases, 20(4), 724-726. https://dx.doi.org/10.3201/eid2004.131409.
  • St. Louis Encephalitis Virus Infection in Woman, Peru PDF Version [PDF - 315 KB - 3 pages]
    V. Felices et al.
            Cite This Article
    EID Felices V, Ampuero JS, Guevara C, Caceda ER, Gomez J, Santiago-Maldonado FW, et al. St. Louis Encephalitis Virus Infection in Woman, Peru. Emerg Infect Dis. 2014;20(4):730-732. https://dx.doi.org/10.3201/eid2004.131735
    AMA Felices V, Ampuero JS, Guevara C, et al. St. Louis Encephalitis Virus Infection in Woman, Peru. Emerging Infectious Diseases. 2014;20(4):730-732. doi:10.3201/eid2004.131735.
    APA Felices, V., Ampuero, J. S., Guevara, C., Caceda, E. R., Gomez, J., Santiago-Maldonado, F. W....Halsey, E. S. (2014). St. Louis Encephalitis Virus Infection in Woman, Peru. Emerging Infectious Diseases, 20(4), 730-732. https://dx.doi.org/10.3201/eid2004.131735.
  • Pandemic Vibrio parahaemolyticus, Maryland, USA, 2012 PDF Version [PDF - 303 KB - 3 pages]
    J. Haendiges et al.
            Cite This Article
    EID Haendiges J, Rock M, Myers RA, Brown EW, Evans P, Gonzalez-Escalona N, et al. Pandemic Vibrio parahaemolyticus, Maryland, USA, 2012. Emerg Infect Dis. 2014;20(4):718-720. https://dx.doi.org/10.3201/eid2004.130818
    AMA Haendiges J, Rock M, Myers RA, et al. Pandemic Vibrio parahaemolyticus, Maryland, USA, 2012. Emerging Infectious Diseases. 2014;20(4):718-720. doi:10.3201/eid2004.130818.
    APA Haendiges, J., Rock, M., Myers, R. A., Brown, E. W., Evans, P., & Gonzalez-Escalona, N. (2014). Pandemic Vibrio parahaemolyticus, Maryland, USA, 2012. Emerging Infectious Diseases, 20(4), 718-720. https://dx.doi.org/10.3201/eid2004.130818.
  • Serologic Evidence of Leptospirosis in Humans, Union of the Comoros, 2011 PDF Version [PDF - 286 KB - 3 pages]
    Y. Gomard et al.
            Cite This Article
    EID Gomard Y, Silai R, Hoarau G, Bon K, Gonneau F, Yssouf A, et al. Serologic Evidence of Leptospirosis in Humans, Union of the Comoros, 2011. Emerg Infect Dis. 2014;20(4):720-722. https://dx.doi.org/10.3201/eid2004.131207
    AMA Gomard Y, Silai R, Hoarau G, et al. Serologic Evidence of Leptospirosis in Humans, Union of the Comoros, 2011. Emerging Infectious Diseases. 2014;20(4):720-722. doi:10.3201/eid2004.131207.
    APA Gomard, Y., Silai, R., Hoarau, G., Bon, K., Gonneau, F., Yssouf, A....Tortosa, P. (2014). Serologic Evidence of Leptospirosis in Humans, Union of the Comoros, 2011. Emerging Infectious Diseases, 20(4), 720-722. https://dx.doi.org/10.3201/eid2004.131207.
  • Whole-Genome Sequencing for Risk Assessment of Long-term Shiga Toxin–producing Escherichia coli PDF Version [PDF - 269 KB - 3 pages]
    J. Knobloch et al.
            Cite This Article
    EID Knobloch J, Niemann S, Kohl TA, Lindner U, Nitschke M, Sayk F, et al. Whole-Genome Sequencing for Risk Assessment of Long-term Shiga Toxin–producing Escherichia coli. Emerg Infect Dis. 2014;20(4):732-733. https://dx.doi.org/10.3201/eid2004.131782
    AMA Knobloch J, Niemann S, Kohl TA, et al. Whole-Genome Sequencing for Risk Assessment of Long-term Shiga Toxin–producing Escherichia coli. Emerging Infectious Diseases. 2014;20(4):732-733. doi:10.3201/eid2004.131782.
    APA Knobloch, J., Niemann, S., Kohl, T. A., Lindner, U., Nitschke, M., Sayk, F....Solbach, W. (2014). Whole-Genome Sequencing for Risk Assessment of Long-term Shiga Toxin–producing Escherichia coli. Emerging Infectious Diseases, 20(4), 732-733. https://dx.doi.org/10.3201/eid2004.131782.
  • Lack of MERS Coronavirus but Prevalence of Influenza Virus in French Pilgrims after 2013 Hajj PDF Version [PDF - 287 KB - 3 pages]
    P. Gautret et al.
            Cite This Article
    EID Gautret P, Charrel R, Benkouiten S, Belhouchat K, Nougairede A, Drali T, et al. Lack of MERS Coronavirus but Prevalence of Influenza Virus in French Pilgrims after 2013 Hajj. Emerg Infect Dis. 2014;20(4):726-728. https://dx.doi.org/10.3201/eid2004.131708
    AMA Gautret P, Charrel R, Benkouiten S, et al. Lack of MERS Coronavirus but Prevalence of Influenza Virus in French Pilgrims after 2013 Hajj. Emerging Infectious Diseases. 2014;20(4):726-728. doi:10.3201/eid2004.131708.
    APA Gautret, P., Charrel, R., Benkouiten, S., Belhouchat, K., Nougairede, A., Drali, T....Parola, P. (2014). Lack of MERS Coronavirus but Prevalence of Influenza Virus in French Pilgrims after 2013 Hajj. Emerging Infectious Diseases, 20(4), 726-728. https://dx.doi.org/10.3201/eid2004.131708.

About the Cover

  • Truth in the Details PDF Version [PDF - 341 KB - 2 pages]
    S. Bloom and E. M. Weeks
            Cite This Article
    EID Bloom S, Weeks EM. Truth in the Details. Emerg Infect Dis. 2014;20(4):734-735. https://dx.doi.org/10.3201/eid2004.AC2004
    AMA Bloom S, Weeks EM. Truth in the Details. Emerging Infectious Diseases. 2014;20(4):734-735. doi:10.3201/eid2004.AC2004.
    APA Bloom, S., & Weeks, E. M. (2014). Truth in the Details. Emerging Infectious Diseases, 20(4), 734-735. https://dx.doi.org/10.3201/eid2004.AC2004.

Etymologia

  • Etymologia: Pertactin PDF Version [PDF - 290 KB - 1 page]
            Cite This Article
    EID Etymologia: Pertactin. Emerg Infect Dis. 2014;20(4):633. https://dx.doi.org/10.3201/eid2004.ET2004
    AMA Etymologia: Pertactin. Emerging Infectious Diseases. 2014;20(4):633. doi:10.3201/eid2004.ET2004.
    APA (2014). Etymologia: Pertactin. Emerging Infectious Diseases, 20(4), 633. https://dx.doi.org/10.3201/eid2004.ET2004.
TOP